Independent medicine information from a GPhC-registered UK pharmacy · Checked against NHS, MHRA and NICE sources

Medicine information

Modafinil vs armodafinil: what’s the difference in the UK?

Modafinil vs armodafinil explained for UK readers: how the two mirror-image forms are related, why only modafinil is licensed in the UK, how they differ in the body, the warnings they share and the legal position.

Last updated 9 November 2026

Written by the Your Meds UK editorial team · Sources: NHS, MHRA, NICE, EMC

Illustration of a pair of teal mittens laid as mirror images on a sunny windowsill

Modafinil vs armodafinil comes down to one molecule and its mirror image. Modafinil is a 50:50 mix of two mirror-image forms, and armodafinil is just one of them, the longer-lasting “R” form. In the UK, modafinil is licensed only for excessive sleepiness in adults with narcolepsy, and armodafinil is not licensed for clinical use at all.

Key facts

  • What they are: wakefulness-promoting medicines. Armodafinil is the R-enantiomer (one mirror-image form) of modafinil.
  • Licensed use (UK): modafinil – excessive sleepiness linked to narcolepsy, with or without cataplexy, in adults. Armodafinil – no UK licence.
  • Legal status: modafinil is a prescription-only medicine (POM). Neither medicine appears on the Home Office list of commonly encountered controlled drugs.
  • Needs a prescription: Yes
  • Last checked: November 2026

How are modafinil and armodafinil related?

Some molecules come in two forms that are mirror images of each other, like your left and right hands. Chemists call these enantiomers. They contain the same atoms but can behave a little differently in the body.

The UK modafinil Summary of Product Characteristics (SmPC) describes modafinil as a racemic compound. That means it contains equal amounts of both forms. The US prescribing information for Nuvigil states that armodafinil is the R-enantiomer of modafinil, which is a 1:1 mixture of the R- and S-forms.

So armodafinil is not a new or different drug in the usual sense. It is the R-half of modafinil, sold on its own. The UK Teratology Information Service also notes that it has the same pharmacodynamic effects, meaning it acts on the body in the same way.

UK licence status side by side

This is the biggest difference for anyone in the UK, and most comparison pages miss it because they are written for US readers.

Modafinil Armodafinil
What it contains Both R- and S-forms (racemic) R-form only
UK licence Yes – excessive sleepiness with narcolepsy in adults Not licensed for clinical use in the UK
Listed on the UK medicines compendium (eMC) Yes – UK SmPC and patient leaflet No UK product listed
US approval Provigil Nuvigil, first approved 2007
US licensed uses Not covered here (US-only) Sleepiness with obstructive sleep apnoea, narcolepsy or shift work disorder
Under-18s Should not take it (UK leaflet) No UK licence for any age

The UK Teratology Information Service (UKTIS) states that armodafinil is not licensed for clinical use in the UK. A search of the eMC, where UK medicine leaflets are published, returns no armodafinil product.

Why armodafinil’s US uses are not licensed for modafinil in the UK

In the US, the Nuvigil label lists three uses: excessive sleepiness with obstructive sleep apnoea (OSA), narcolepsy or shift work disorder. The UK went the other way for modafinil.

In May 2009 the UK medicines regulator asked for a Europe-wide safety review of modafinil. In 2010 the European Medicines Agency (EMA) concluded that its benefits outweigh its risks only in narcolepsy. It recommended removing OSA, shift work sleep disorder and idiopathic hypersomnia from the licence. The review looked at skin reactions, psychiatric side effects and heart-related side effects.

So the US conditions that armodafinil is licensed for include two that European regulators decided modafinil should no longer treat. Our modafinil guide explains the current UK licence in full.

Do they work differently in the body?

Because armodafinil is part of modafinil, the main difference is how long each form stays in your blood. The two mirror-image forms are cleared at different speeds.

  • The UK SmPC says the R-form’s elimination half-life is three times that of the S-form in adults.
  • The 2017 US Nuvigil prescribing information gives the S-form’s half-life as about 4 hours.
  • The UK SmPC gives modafinil an effective half-life of about 15 hours after repeated doses. Peak levels come about 2 to 4 hours after a dose.

The same US label reports a study at steady state. With the same 200 mg amount, peak armodafinil levels were about 37% higher, and total exposure about 70% higher, than with modafinil. This happened because the shorter-lived S-form is cleared faster.

These figures describe blood levels in a study. They are not a dose conversion. You cannot use them to work out an “equivalent” amount of one medicine from the other, and nobody should switch between them without their specialist.

Side effects and warnings they share

As armodafinil is a component of modafinil, the main safety warnings overlap. The UK modafinil SmPC includes warnings on:

  • Serious skin rashes, including Stevens–Johnson syndrome, and multi-organ allergic reactions.
  • Mental health effects, such as anxiety, psychotic or manic symptoms, aggression and suicidal thoughts.
  • Heart and blood pressure risks.
  • Hormonal contraception working less well. The UK leaflet advises other methods during treatment and for two months after stopping.
  • Abuse, misuse, diversion and dependence.

The US Nuvigil label carries similar warnings, including serious skin reactions, psychiatric symptoms, effects on driving and heart-related events. Read more in our guides to modafinil side effects and modafinil interactions.

Pregnancy

UKTIS groups modafinil and armodafinil data together and says the teratogenic potential of modafinil is unclear. The manufacturer advises that modafinil should not be used in pregnancy. See modafinil, pregnancy and contraception.

Driving

The SmPC warns that your wakefulness may not return to normal on treatment. Blurred vision or dizziness can also affect driving. The NHS narcolepsy page reminds you that you must tell the DVLA if you drive and have narcolepsy.

Legal status in the UK

In the UK, modafinil is a prescription-only medicine. It is not on the Home Office list of commonly encountered controlled drugs, and nor is armodafinil. The Home Office notes that its list is not exhaustive.

In the US, both are Schedule IV controlled substances. That US label does not apply in the UK, which is a common source of confusion online. Our article Is modafinil legal in the UK? covers the law in more detail.

If you travel, GOV.UK says you can only bring up to 3 months’ supply of your medicine into the UK.

Armodafinil sold online: the risks

Because armodafinil has no UK licence, any armodafinil offered to UK buyers online has not been assessed for the UK market. You cannot check it against a UK patient leaflet, and you may not know what the tablets really contain.

The MHRA has warned that it is a criminal offence to supply prescription-only medicines without a valid prescription. It lists possible risks of so-called cognitive enhancers as dependence, heart problems and psychosis. It also stresses that modafinil is not licensed as a “boost” for exams. Our guide on modafinil as a ‘smart drug’ looks at that evidence.

To check whether a UK website is a legitimate pharmacy, see how to check a UK online pharmacy.

Talking to your specialist

If you have narcolepsy and modafinil is not working well, or you read about armodafinil, raise it with your sleep specialist. Useful questions include:

  • Is my current treatment still the best option for my symptoms?
  • Are there licensed alternatives or non-drug changes that could help?
  • What should I watch for, such as rashes, mood changes or chest symptoms?

Take modafinil exactly as your prescriber tells you. The NHS also suggests a regular bedtime routine, planned naps and avoiding alcohol. You can find more on the condition in our narcolepsy hub.

When to get help

Call 999 or go to A&E if you or someone else has:

  • a widespread rash with blistering, peeling skin, or sores in the mouth, eyes or genitals
  • swelling of the face, lips or throat, or difficulty breathing
  • chest pain, or thoughts of harming yourself

Call NHS 111 or speak to your prescriber if you notice any rash, mood changes, a racing heartbeat or anything else that worries you.

You can report suspected side effects, or a medicine you think may be fake, through the MHRA Yellow Card scheme.

Frequently asked questions

Is armodafinil stronger than modafinil?

Armodafinil is not a different medicine but the longer-lasting half of modafinil. A US study found higher blood levels with the same amount, but this is not a measure of being “stronger” or a basis for comparing doses.

What does Reddit say about armodafinil vs modafinil?

Forum posts describe personal experiences, often with unlicensed products of unknown quality. They are not evidence about safety or effect. For decisions about your treatment, rely on your prescriber and the official UK leaflet.

Can you take armodafinil and modafinil together?

No. Armodafinil is already part of modafinil, so taking both would mean taking more of the same active ingredient. Never combine or swap them yourself.

Is armodafinil available on the NHS?

Armodafinil is not licensed for clinical use in the UK, and no UK product is listed on the eMC. Modafinil is the licensed option, for adults with narcolepsy.

Is armodafinil a controlled drug in the UK?

Armodafinil is not on the Home Office list of commonly encountered controlled drugs. It is a Schedule IV controlled substance in the US, which is a different legal system.

References

  1. Modafinil 100mg tablets – Summary of Product Characteristics, Milpharm Ltd via emc, accessed November 2026
  2. Modafinil 100mg tablets – Patient Information Leaflet, Milpharm Ltd via emc, accessed November 2026
  3. Use of modafinil in pregnancy, UK Teratology Information Service, April 2025, accessed November 2026
  4. Modafinil – referral (Article 31), European Medicines Agency, accessed November 2026
  5. Nuvigil (armodafinil) tablet – label, DailyMed, US National Library of Medicine, accessed November 2026
  6. Nuvigil (armodafinil) prescribing information, revised 02/2017, US Food and Drug Administration, accessed November 2026
  7. List of most commonly encountered drugs currently controlled under the misuse of drugs legislation, Home Office, accessed November 2026
  8. Freshers warned to be smart and avoid Modafinil, MHRA, 26 September 2016, accessed November 2026
  9. Narcolepsy, NHS, accessed November 2026
  10. Take medicine in or out of the UK, GOV.UK, accessed November 2026
  11. Yellow Card scheme, MHRA, accessed November 2026

This article is for information only and does not replace advice from your doctor or pharmacist. Read our medical disclaimer.

Questions about your own medicine?

Speak to the doctor or pharmacist who looks after you before you start, change or stop any medicine. If you think you are having a serious reaction, call 999.